Oramed Pharmaceuticals Inc.

US$3.86As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ORMPHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (4.60%)
Div yield 6.48%
ROE 74.24%
Biotechnology
Beta (5Y) 1.28
PE TTM 0.931
TSR TTM 73.24%
Mkt cap US$160.6M
ROIC (5.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.74
(3.13%)
145.00%
Buy 6|7|5|7|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.06
7.10%
1.49%
2.14%
(2.09%)
Revenue$M
8.254
8.059
8.255
8.102
(1.25%)
(0.83%)
(0.01%)
(2.21%)
Peers (US$160.6M)
Cap (US$)
PE
161.1M
—
Capital
TTM
5Y
10Y
Leveragex
0.799
1.967
1.576
EBIT/Intx
0.273
0.379
0.398
Own earn%
(156.05)
23.79
37.16
Sh yield%
53.97
39.38
37.82
Owners
Insiders/Inst%
9.54
38.48
Short interest%
4.89
SBC / revenue%
2.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
0–7
$1 testx
—
Incr. ROIC%
4